In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 25th, 2008 | 21 | Yes |
Popular Name: (1S,2S)-2-[(1R,5S)-3-phenyl-8-azabicyclo[3.2.1]octan-8-yl]cyclohexan-1-ol (1S,2S)-2-[(1R,5S)-3-phenyl-8-az…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.94 | 8.14 | -29.36 | 2 | 2 | 1 | 25 | 286.439 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SC6A3-1-E | Dopamine Transporter (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2813 | 0.37 | Binding ≤ 10μM |
SC6A4-3-E | Serotonin Transporter (cluster #3 Of 4), Eukaryotic | Eukaryotes | 3422 | 0.36 | Binding ≤ 10μM |
SGMR1-1-E | Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 380 | 0.43 | Binding ≤ 10μM |
VACHT-1-E | Vesicular Acetylcholine Transporter (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9 | 0.54 | Binding ≤ 10μM |
Z100491-1-O | Sigma 2 Receptor (cluster #1 Of 2), Other | Other | 118 | 0.46 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Z100491 | Z100491 | Sigma 2 Receptor | 118 | 0.46 | Binding ≤ 1μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 380 | 0.43 | Binding ≤ 1μM |
VACHT_HUMAN | Q16572 | Vesicular Acetylcholine Transporter, Human | 8.5 | 0.54 | Binding ≤ 1μM |
SC6A3_RAT | P23977 | Dopamine Transporter, Rat | 2813 | 0.37 | Binding ≤ 10μM |
SC6A4_RAT | P31652 | Serotonin Transporter, Rat | 3422 | 0.36 | Binding ≤ 10μM |
Z100491 | Z100491 | Sigma 2 Receptor | 118 | 0.46 | Binding ≤ 10μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 380 | 0.43 | Binding ≤ 10μM |
VACHT_HUMAN | Q16572 | Vesicular Acetylcholine Transporter, Human | 8.5 | 0.54 | Binding ≤ 10μM |
Description | Species |
---|---|
Acetylcholine Neurotransmitter Release Cycle | |
Dopamine clearance from the synaptic cleft | |
Na+/Cl- dependent neurotransmitter transporters |